ChemPartner PharmaTech Co

ChemPartner PharmaTech Co Assets per Share

The Total Assets per Share of ChemPartner PharmaTech Co (300149.SZ) as of Oct 30, 2026 is 4.08 CNY. In the previous year, Total Assets per Share was 4.01 CNY — a change of 1.86% (higher).

Assets per Share

4.08CNY

YoY

1.86%

Last updated:

Total Assets per Share of ChemPartner PharmaTech Co is 2025 4.08 CNY. Total Assets per Share of ChemPartner PharmaTech Co was 2024 4.01 CNY. It decreases by 1.86% higher compared to the previous year.

The ChemPartner PharmaTech Co Assets per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Assets per Share
Date
Assets per Share
Jan 1, 2018
6.72 CNY
Jan 1, 2019
7.57 CNY
Jan 1, 2020
8.28 CNY
Jan 1, 2021
8.47 CNY
Jan 1, 2022
7.68 CNY
Jan 1, 2023
4.89 CNY
Jan 1, 2024
4.01 CNY
Jan 1, 2025
4.08 CNY
The ChemPartner PharmaTech Co Assets per Share history
YEARAssets per ShareYoY
4.08CNY+1.86%
4.01CNY-18.01%
4.89CNY-36.34%
7.68CNY-9.33%
8.47CNY+2.33%
8.28CNY+9.39%
7.57CNY+12.55%
6.72CNY+220.91%
2.09CNY+31.52%
1.59CNY+4.92%
1.52CNY+2.01%
1.49CNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

ChemPartner PharmaTech Co Stock analysis

What does ChemPartner PharmaTech Co do? ChemPartner PharmaTech Co., Ltd. generates revenue through the research, development, production, and sale of prebiotic products, primarily fructooligosaccharides and galactooligosaccharides. The company markets its products under the brand names FOS and GOS, targeting the nutrition and health, dairy, beverage, bakery, and functional snack food industries. Domestic distribution dominates, with South China as the core market, serving manufacturers of food and health products. The firm's product portfolio focuses on fructooligosaccharides and galactooligosaccharides, sold as FOS and GOS, which are integrated into various consumer goods. These prebiotics are essential ingredients in dairy, beverages, baked goods, and functional snacks, meeting demand from food producers seeking health-enhancing additives. South China remains the primary sales region, aligning with the company's domestic market strategy. ChemPartner PharmaTech's revenue streams derive from B2B sales to food and beverage manufacturers, particularly those producing nutrition and health products, dairy, and functional snacks. The company's brands FOS and GOS are positioned as key ingredients for health-focused consumer goods, with sales concentrated in South China, the main market for its domestic distribution network. ChemPartner PharmaTech Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ChemPartner PharmaTech Co stock

Total Assets per Share of ChemPartner PharmaTech Co is 4.08 CNY in 2025.

Total Assets per Share of ChemPartner PharmaTech Co changed from 4.01 CNY to 4.08 CNY, representing a 1.86% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Total Assets per Share ChemPartner PharmaTech Co since 2006 – with annual values, charts, and detailed analysis.

Assets per share divides total assets by shares outstanding, indicating the total resource base backing each share of stock.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Other — ChemPartner PharmaTech Co

All Key Metrics — ChemPartner PharmaTech Co